Adrixetinib
Adrixetinib (Q702) is an Axl/Mer/CSF1R protein tyrosine kinase inhibitor with antineoplastic activity[1][2].
Product Specifications
CAS Number
[2394874-66-7]
Product Name Alternative
Q702
UNSPSC
12352005
Target
C-Fms; TAM Receptor
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/adrixetinib.html
Purity
99.51
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(C1=NN(CCC)C=C1OCC(F)(F)F)NC2=NC=C(C=C2)OC3=C4C=C(OC)C(OC)=CC4=NC=C3
Molecular Formula
C25H24F3N5O5
Molecular Weight
531.48
References & Citations
[1]WHO Drug Informat ion - World Health Organization (WHO) .|[2]Nam Kiyean, et al. Quinoline derivatives as inhibitors of Axl/Mer RTK and CSF1R and their preparation: World Intellectual Property Organization, WO2019229251. 2019-12-05.|[3]WHO Drug Information-World Health Organization (WHO) .
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
38285124 3x 1.0µg DNA
R3HDM2 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Ask
View Details 
125687-FITC 100 µL
DCUN1D1 (DCN1-like Protein 1, DCUN1 Domain-containing Protein 1, Defective in Cullin Neddylation Protein 1-like Protein 1, Squamous Cell Carcinoma-related Oncogene, DCUN1L1, RP42, SCCRO) (FITC)
Ask
View Details